Riskpilot← Back to searchSign inGet full accessBWT Pharma & Biotech AB
ABActiveOrg 5565860920Kantyxegatan 25Installation of industrial machinery and equipment · NACE 3320Est. 200050 employees
Revenue 2024
SEK 735M
+52% vs 2023
EBITDA margin
20.7%
+99% vs 2023
Equity ratio
33.3%
Financial strength
Net profit 2024
SEK 123,4M
+100% vs 2023
| Revenue | SEK 735M | +52% |
| EBITDA | SEK 151,9M | +99% |
| Net profit | SEK 123,4M | +100% |
| Total assets | SEK 534M | +50% |
| Equity | SEK 177,9M | +88% |
| Employees | 50 | — |
Legal name
BWT Pharma & Biotech AB
Org number
5565860920
Legal form
Aktiebolag
NACE code
3320 · Installation of industrial machinery and equipment
Founded
22 februari 2000
Share capital
SEK 500 000
Employees
50 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolaget ska bedriva försäljning, ge design åt, installera och serva maskiner, som renar vatten samt därmed förenlig verksamhet.
Address
Kantyxegatan 25
Email
info@christ.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 203 779 | 203 082 | 332 340 | 484 991 | 735 019 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 175 | 24 872 | 48 586 | 76 231 | 151 919 |
| Depreciation & amort. | −439 | −450 | −469 | −603 | −733 |
| EBIT | 1 736 | 24 422 | 48 117 | 75 628 | 151 186 |
| Net financials | 21 | −27 | 126 | 2 239 | 4 771 |
| Profit before tax | 1 506 | 24 409 | 48 288 | 77 929 | 155 950 |
| Tax | −431 | −5 189 | −10 284 | −16 312 | −32 592 |
| Net profit | 1 075 | 19 220 | 38 004 | 61 617 | 123 358 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 102 146 | 142 995 | 202 543 | 355 614 | 534 041 |
| Equity | 15 718 | 34 939 | 52 943 | 94 560 | 177 919 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 65 685 | 84 773 | 139 065 | 258 862 | 353 534 |
| Total debt | 65 685 | 84 773 | 139 065 | 258 862 | 353 534 |
EBITDA margin
20.7%
This company
15.8%
Market median
+31% vs market
20202024
Equity ratio
33.3%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
69.3%
This company
18.4%
Market median
+277% vs market
20202024
Net profit margin
16.8%
This company
8.1%
Market median
+107% vs market
20202024
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20202024
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
CM Chief Executive Officer | Chief Executive Officer | 2020 |
OC Chief Auditor | Chief Auditor | 2022 |
| Former (2) | ||
KO Chief Auditor | Chief Auditor | 2022 – 2022 |
PA Chief Auditor | Chief Auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
P&LS HOLDING GMBH
BWT Pharma & Biotech AB (this company)Board members of BWT Pharma & Biotech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Olof Andersson | Chief Auditor | 0 companies |
| Cay Mikael Mats Månsson | Chief Executive Officer | 0 companies |
| Ove Christofer Hultén | Chief Auditor | 0 companies |
| Pia Agneta Anell | Chief Auditor | 0 companies |
| Henrik Forslund | Chairman | 0 companies |
| Horst Stautmeister Stephan | Board of Directors | 0 companies |